128 related articles for article (PubMed ID: 28687341)
1. Carbenoxolone prevents chemical eye ischemia-reperfusion-induced cell death via 11β-hydroxysteroid dehydrogenase type 1 inhibition.
Choi KJ; Na YJ; Park SB; Jung WH; Sung HR; Kim KY
Pharmacol Res; 2017 Sep; 123():62-72. PubMed ID: 28687341
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma.
Choi KJ; Na YJ; Jung WH; Park SB; Kang S; Nam HJ; Ahn JH; Kim KY
Biochem Pharmacol; 2019 Nov; 169():113632. PubMed ID: 31494147
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of carbenoxolone, an 11β-HSD1 inhibitor, against chemical induced dry eye syndrome.
Na YJ; Choi KJ; Park SB; Sung HR; Jung WH; Kim HY; Rhee SD; Kim KY
Apoptosis; 2017 Nov; 22(11):1441-1453. PubMed ID: 28887719
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effect of a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor via the stimulation of heme oxygenase-1 in LPS-activated mice and J774.1 murine macrophages.
Park SB; Park JS; Jung WH; Kim HY; Kwak HJ; Ahn JH; Choi KJ; Na YJ; Choi S; Dal Rhee S; Kim KY
J Pharmacol Sci; 2016 Aug; 131(4):241-50. PubMed ID: 27523796
[TBL] [Abstract][Full Text] [Related]
5. Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice.
Tiganescu A; Hupe M; Uchida Y; Mauro T; Elias PM; Holleran WM
Endocrinology; 2018 Jan; 159(1):547-556. PubMed ID: 29087473
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension.
Rauz S; Cheung CM; Wood PJ; Coca-Prados M; Walker EA; Murray PI; Stewart PM
QJM; 2003 Jul; 96(7):481-90. PubMed ID: 12881590
[TBL] [Abstract][Full Text] [Related]
7. Sub-chronic administration of the 11beta-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity.
Taylor A; Irwin N; McKillop AM; Flatt PR; Gault VA
Biol Chem; 2008 Apr; 389(4):441-5. PubMed ID: 18225986
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel 11β-HSD1 inhibitor from a high-throughput screen of natural product extracts.
Park SB; Park JS; Jung WH; Park A; Jo SR; Kim HY; Dal Rhee S; Ryu SY; Jeong HG; Park S; Lee H; Kim KY
Pharmacol Res; 2015 Dec; 102():245-53. PubMed ID: 26515507
[TBL] [Abstract][Full Text] [Related]
9. Carbenoxolone treatment ameliorated metabolic syndrome in WNIN/Ob obese rats, but induced severe fat loss and glucose intolerance in lean rats.
Prasad Sakamuri SS; Sukapaka M; Prathipati VK; Nemani H; Putcha UK; Pothana S; Koppala SR; Ponday LR; Acharya V; Veetill GN; Ayyalasomayajula V
PLoS One; 2012; 7(12):e50216. PubMed ID: 23284633
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice.
Dhanesha N; Joharapurkar A; Shah G; Kshirsagar S; Dhote V; Sharma A; Jain M
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):69-77. PubMed ID: 22060140
[TBL] [Abstract][Full Text] [Related]
11. Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.
Liu Y; Nakagawa Y; Wang Y; Liu L; Du H; Wang W; Ren X; Lutfy K; Friedman TC
J Mol Endocrinol; 2008 Aug; 41(2):53-64. PubMed ID: 18524870
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of 11beta-hydroxysteroid dehydrogenase activity in the rabbit eye.
Anderson S; Carreiro S; Quenzer T; Gale D; Xiang C; Gukasyan H; Lafontaine J; Cheng H; Krauss A; Prasanna G
J Ocul Pharmacol Ther; 2009 Jun; 25(3):215-22. PubMed ID: 19456256
[TBL] [Abstract][Full Text] [Related]
13. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
Livingstone DE; Walker BR
J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
[TBL] [Abstract][Full Text] [Related]
14. A Novel Selective 11β-HSD1 Inhibitor, (E)-4-(2-(6-(2,6-Dichloro-4-(Trifluoromethyl)Phenyl)-4-Methyl-1,1-Dioxido-1,2,6-Thiadiazinan-2-yl)Acetamido)Adamantan-1-Carboxamide (KR-67607), Prevents BAC-Induced Dry Eye Syndrome.
Na YJ; Choi KJ; Jung WH; Park SB; Kang S; Ahn JH; Kim KY
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466320
[TBL] [Abstract][Full Text] [Related]
15. Anti-diabetic and anti-inflammatory effect of a novel selective 11β-HSD1 inhibitor in the diet-induced obese mice.
Park SB; Jung WH; Kang NS; Park JS; Bae GH; Kim HY; Rhee SD; Kang SK; Ahn JH; Jeong HG; Kim KY
Eur J Pharmacol; 2013 Dec; 721(1-3):70-9. PubMed ID: 24135201
[TBL] [Abstract][Full Text] [Related]
16. Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzyme.
Schweizer RA; Zürcher M; Balazs Z; Dick B; Odermatt A
J Biol Chem; 2004 Apr; 279(18):18415-24. PubMed ID: 14973125
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.
Tomlinson JW; Sherlock M; Hughes B; Hughes SV; Kilvington F; Bartlett W; Courtney R; Rejto P; Carley W; Stewart PM
J Clin Endocrinol Metab; 2007 Mar; 92(3):857-64. PubMed ID: 17200165
[TBL] [Abstract][Full Text] [Related]
18. Acute anti-obesity effects of intracerebroventricular 11β-HSD1 inhibitor administration in diet-induced obese mice.
Seo M; Islam SA; Moon SS
J Neuroendocrinol; 2018 Mar; 30(3):e12580. PubMed ID: 29418022
[TBL] [Abstract][Full Text] [Related]
19. 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells.
Lee SE; Lee EY; Kang SJ; Lee SH
Yonsei Med J; 2017 Nov; 58(6):1204-1210. PubMed ID: 29047245
[TBL] [Abstract][Full Text] [Related]
20. Local modulation by 11beta-hydroxysteroid dehydrogenase of glucocorticoid effects on the activity of 15-hydroxyprostaglandin dehydrogenase in human chorion and placental trophoblast cells.
Patel FA; Sun K; Challis JR
J Clin Endocrinol Metab; 1999 Feb; 84(2):395-400. PubMed ID: 10022390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
